Published on Nov 27, 2023
Authored by Pfizer Medical Team
Clinical trials are studies that look at potential new medicines, combinations of medicines, or new ways to use current medicines1, for the treatment of people affected by diseases such as multiple myeloma2. There are many types of clinical trials and they are categorised into different phases, and all phases are designed to answer specific questions1,3.
Before taking part in a clinical trial, it is important to know if it is the right decision for you4.
Please visit Understanding Clinical Trials and Research for more information about the clinical trial process, including the different clinical steps or ‘phases’ involved.
Your healthcare team may discuss your taking part in a clinical trial with you. Like all treatment options, investigational treatments for multiple myeloma that are given to participants in clinical trials have their own potential benefits and risks1,4, and it’s important to understand what these might be so that you can make an informed decision about your participation. Some examples of benefits and risks can be found below.
Taking part in clinical trials is free for Australian citizens and residents1,4. The cost of trial-related treatments, tests and check-ups will be paid for by the organization or company that is funding or conducting the research/clinical trial (sponsor1). Some of these tests and treatments are part of the standard of care.
Any additional costs related to the extra care that patients need when taking part in a clinical trial, such as more doctor’s visits, more hospital stays, more tests as well as travel, housing if required, food and childcare will be covered by the sponsor. The clinical trial team will outline what expenses will be covered4.
Before a person with multiple myeloma can join a specific clinical trial, they must meet certain requirements. These requirements are known as inclusion and exclusion criteria1. Please visit Understanding Clinical Trials and Research to find out more about these criteria, and the process of informed consent. If you are interested in taking part in a clinical trial, then speak to your healthcare team.
It is important to know that once enrolled in a clinical trial, participants have the right to leave the trial at any time and for any reason1. All participants are informed of this right before they enroll. Your clinical trial team will be able to give guidance on what happens should you decide to leave the trial at any point, including any safety check-ups that would still need to take place. Your personal and health-related information collected during the trial is required to be kept private, and will not be shared with anyone who is not working on the clinical trial without your permission1.
There are several treatments for multiple myeloma currently being investigated in clinical trials.
If you want advice on finding clinical trials, or are looking for clinical trials in people with multiple myeloma, please visit the following websites: